Normal saline is a cornerstone of intravenous solutions commonly used in the clinical setting. It is a crystalloid fluid administered via an intravenous solution. Its indications include both adult and pediatric populations as sources of hydration and electrolyte disturbances. It can come in various concentrations; the two specifically addressed are 0.9% and 0.45%.
The following are primary indications for the use of normal saline infusion that have been approved by the FDA:
Additionally, it has a use as a priming solution for various procedures (e.g., hemodialysis procedures), and to initiate and terminate blood transfusions. Indications for sodium chloride infusions also include pharmaceutic aids and diluents for the infusion of compatible drug additives.
0.9% Normal Saline:
An isotonic concentration of sodium chloride, which is best suited for parenteral replacement of chloride losses that exceed or equal the sodium loss. Within each 100 mL of 0.9% sodium chloride Injection USP, there is 154 mEq of sodium ions and 154 mEq of chloride ions. Additionally, the osmolarity is 308 mOsmol/liter and a pH range of 4.5 to 7.
0.45% Normal Saline:
A hypotonic concentration of sodium chloride. Hypotonic concentrations of sodium chloride (0.45%) are best for parenteral maintenance fluids, rather than aggressive intravascular volume repletion. Within each 100 mL of 0.45% sodium chloride Injection USP, there is 77 mEq of sodium ions and 77 mEq of chloride ions. The osmolarity is 154 mOsmol/liter and pH range that is similar to the 0.9% concentration.
Normal saline is a crystalloid fluid. By definition, it is an aqueous solution of electrolytes and other hydrophilic molecules. The main indication for the use of crystalloid fluids in humans is due to its isotonic nature when compared to serum plasma. In comparison to other types of fluids (e.g., hypertonic, hypotonic), there is less of an osmotic effect. Normal saline contains electrolytes (sodium and chloride ions) which dissociates in solution.
Sodium ions are the main electrolytes of extracellular fluid, which is integral in the distribution of fluids and other electrolytes. Another important ion is chloride, which serves a role as a buffering agent within the lungs and tissues. Here chloride helps to facilitate binding between oxygen and carbon dioxide to hemoglobin. These ions are primarily under the regulation of the kidneys, which controls homeostasis by absorption or excretion within the tubules.
Additionally, water plays an equally important role. Water is a necessary ingredient of the body and comprises more than two-thirds of total body weight. Similarly, the balance of water is primarily under the control of the lungs and kidneys. The distribution of water depends mainly on the concentration of these electrolytes within various compartments. Within these compartments, sodium plays a significant role in sustaining homeostatic concentrations and the distribution of water. Normal saline functions to expand intravascular volume without disturbing ion concentration or causing large fluid shifts between intracellular, intravascular, and interstitial spaces.
Normal saline solution can be administered only via intravenous access. When deciding dosage, the provider must take into account various patient factors (e.g., weight, age, clinical presentation, laboratory findings). Therefore, monitoring should focus on laboratory results and clinical evaluation (see ‘Monitoring’ section). Naturally, there are two methods of administration for normal saline:
1) Fluid Bolus:
For a 50kg patient
First 10 kg weight = 1000 mL (100 mL/kg x 10)
Second 10 kg weight = 500 mL (50 mL/kg x 10)
Remaining 30 kg weight = 750 mL (25 mL/kg x 30)
Total = 2250 mL/day or 94 mL/hr
First 10 kg weight = 4 mL/kg/hr x 10 = 40 mL/hr
Second 10 kg weight = 2 mL/kg/hr x 10 = 20 mL/hr
Remaining 30 kg weight = 1 mL/kg/hr x 30 = 30 mL/hr
Total = 100 mL/hr
The use of normal saline can contribute to iatrogenic fluid overload. This complication is particularly concerning in patients with impaired kidney function (acute kidney injury, chronic kidney disease, etc.) and these patients should, therefore, receive treatment with judicious use of intravenous fluids.
Patients with congestive heart failure are at an increased risk for detrimental effects of normal saline administration. In these patients, fluid overload is a considerable concern; this can lead to life-threatening pulmonary edema and the worsening of a diastolic or systolic heart failure, leading to end-organ damage or even death. It is vital for the clinician to monitor these patients carefully and to administer the minimum required volume to maintain homeostasis.
Adverse effects of normal saline may occur secondary to solution or technique of administration. These effects include febrile response, infection at the site of injection, venous thrombosis, or phlebitis extending from the site of injection, extravasation, and hypervolemia. Additionally, if infusing normal saline 0.9% in large quantities, chloride ions will be vastly increased within the blood. This influx of hyperchlorhydria causes an intracellular shift of bicarbonate ions to allow for equilibria. Overall, this decreases the number of bicarbonate ions available for buffering. Due to the net acidosis, this physiological change will also cause an increase in serum potassium levels due to the transcellular shift of potassium from within the cell into the extracellular space.
While the overuse of 0.45% normal saline can cause hyponatremia and cerebral edema; this is due to its hypotonic nature, creating a migration of water molecules into areas of higher sodium concentration.
Therefore, if an adverse effect does occur, discontinuation of the infusion is strongly suggested. The patient should then undergo a clinical evaluation, and the proper therapeutic countermeasures engaged. All while, the remainder of the fluid should be saved for examination if contamination is suspected.
Contraindications for the use of normal saline are evaluated clinically from patient to patient. If the implementation of normal saline results in dilution of serum electrolyte concentrations, overhydration, congested states or pulmonary edema, then its use is strongly discouraged.
When monitoring the use of normal saline, there must be periodic assessments of the patient’s clinical and laboratory findings. Specifically, one must observe any changes in electrolyte concentrations, volume-status, and acid-base disturbances. Significant deviations from normal concentrations may require tailoring of the electrolyte pattern, in these or alternative solutions.
Patients require evaluation for signs and symptoms of dehydration and fluid overload. Patients with an elevated lactate and creatinine concentration are signs that he/she may not be receiving an adequate amount of volume. Also, the patient's volume status is assessable by monitoring urine output. Ideally, urine output target of 0.5 mL/kg/hr indicates adequate hydration but may not be useful to determine volume status in patients with renal impairment. In such a case, providers must utilize other objective findings to evaluate fluid status (e.g., orthostatic, physical examination).
Patients at high risk of developing fluid overload should receive frequent re-evaluation, especially patients with known cardiopulmonary diseases. Sign and symptoms of fluid overload can undergo an evaluation with a comprehensive physical exam. Clinicians should investigate for pulmonary edema (e.g., new or worsening crackles on lung exam), as well as, any new or worsening peripheral edema in the extremities.
Additionally, the infusion of more than one liter of isotonic (0.9%) sodium chloride per day may supply more sodium and chloride than physiological levels, which can lead to hypernatremia, as well as hyperchloremic metabolic acidosis. Therefore, patients receiving large volumes of normal saline require monitoring for electrolyte imbalances.
To minimize the risk of possible contaminations, the final solution should be inspected for ambiguity or precipitation immediately after mixing, before administration and periodically during administration.
The implementation of normal saline is standard during resuscitation, and administration can be at various concentrations. In most clinical settings, normal saline is the choice of fluid for many indications for fluid resuscitation, maintenance, or as a solvent for medication delivery.
Without proper management, the consequences of adverse effects increase. Therefore, the clinician and nursing staff must perform monitoring and reassessment of the patient and coordinate the reporting of abnormal findings. The following are objective findings that the provider and nursing staff must review:
The management of normal saline requires evaluation alongside the patient’s clinical status. Clinicians, including nurses, must recognize the indications on when to implement this IV solution and when there is a potential for untoward side effects from over-hydration. Due to normal saline's well-known side effects, there have been concerns regarding its use in critically ill patients. Thus nursing reporting to the clinical team unexpected findings is paramount. Hyperchloremia was significantly associated with increased mortality. Pharmacists should have input on the implementation of IV fluids, making suggestions to the ordering physician based on the clinical situation, and providing counsel to nursing regarding dosing and administration. Therefore, the use of normal saline in critically ill patients is being re-investigated. There have been multiple studies comparing the use of other balanced crystalloid fluids, that have shown promising results in decreasing mortality and complication rates. One, in particular, the SMART study in 2018, showed a reduction in death incidence and protection of renal complications in critically ill patients with the use of balanced crystalloids over normal saline. Although additional prospective studies are still needed. One fact is clear; normal saline should be prescribed, just like all other medications, taking into account individual patient factors, disease processes, and other treatments.
Despite its ubiquity in clinical scenarios, normal saline requires an interprofessional approach to dosing and administration among physicians, specialists, nurses, and pharmacists, all working collaboratively as an interprofessional team to optimize patient outcomes. [level V]
|||Chang R,Holcomb JB, Choice of Fluid Therapy in the Initial Management of Sepsis, Severe Sepsis, and Septic Shock. Shock (Augusta, Ga.). 2016 Jul; [PubMed PMID: 26844975]|
|||Epstein EM,Waseem M, Crystalloid Fluids 2019 Jan; [PubMed PMID: 30726011]|
|||Boyd JH,Forbes J,Nakada TA,Walley KR,Russell JA, Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Critical care medicine. 2011 Feb; [PubMed PMID: 20975548]|
|||Holliday MA,Ray PE,Friedman AL, Fluid therapy for children: facts, fashions and questions. Archives of disease in childhood. 2007 Jun; [PubMed PMID: 17175577]|
|||Eisenhut M, Causes and effects of hyperchloremic acidosis. Critical care (London, England). 2006; [PubMed PMID: 16834765]|
|||Matějovič M,Horák J,Harazim M,Karvuni T,Raděj J,Novák I, Intravenous fluid therapy in acutely ill patients for non-intensivists. Vnitrni lekarstvi. 2019 Spring [PubMed PMID: 31088095]|
|||Neyra JA,Canepa-Escaro F,Li X,Manllo J,Adams-Huet B,Yee J,Yessayan L, Association of Hyperchloremia With Hospital Mortality in Critically Ill Septic Patients. Critical care medicine. 2015 Sep; [PubMed PMID: 26154934]|
|||Kellum JA,Song M,Almasri E, Hyperchloremic acidosis increases circulating inflammatory molecules in experimental sepsis. Chest. 2006 Oct; [PubMed PMID: 17035425]|
|||Bhaskaran K,Arumugam G,Vinay Kumar PV, A prospective, randomized, comparison study on effect of perioperative use of chloride liberal intravenous fluids versus chloride restricted intravenous fluids on postoperative acute kidney injury in patients undergoing off-pump coronary artery bypass grafting surgeries. Annals of cardiac anaesthesia. 2018 Oct-Dec [PubMed PMID: 30333337]|
|||Semler MW,Self WH,Wang L,Byrne DW,Wanderer JP,Ehrenfeld JM,Stollings JL,Kumar AB,Hernandez A,Guillamondegui OD,May AK,Siew ED,Shaw AD,Bernard GR,Rice TW, Balanced crystalloids versus saline in the intensive care unit: study protocol for a cluster-randomized, multiple-crossover trial. Trials. 2017 Mar 16 [PubMed PMID: 28302179]|
|||[PubMed PMID: 23817025]|